Table 2 F2R expression correlated with clinical pathological characteristics (logistic regression).

From: Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma

Characteristics

Total (N)

Odds ratio (OR)

p value

Age (> 60 vs. ≤ 60 years)

371

0.720 (0.465–1.113)

0.141

Gender (female vs male)

375

0.992 (0.650–1.514)

0.969

Histological grade (G1 & G2 vs G3 & G4)

366

1.858 (1.2189–2.846)

0.004

Pathological stage (stage II & stage III & stage IV vs stage I)

352

1.979 (1.091–3.684)

0.027

T stage (T2 & T3 & T4 vs T1)

367

2.932 (1.096–9.231)

0.043

M stage (M1 & M0)

355

0.923 (0.404–2.094)

0.847

N stage (N1 & N2 & N3 vs N0)

357

1.471 (0.938–2.317)

0.094

Race (White & Black or African American & Native Hawaiian or Other Pacific Islander vs Asian)

381

1.898 (1.122–3.258)

0.018

Tumour status (with tumour vs tumour free)

381

0.735 (0.437–1.227)

0.241

Residual tumour (R1 & R2 vs R0)

387

0.938 (0.443–1.973)

0.864

  1. Categorical dependent variable, greater or less than the median expression level.
  2. T topography distribution, N lymph node metastasis, M distant metastasis.
  3. Significant values are in bold.